Open AccessCervical cancer screening based on human papilloma virus-DNA testing: a scientific heritage to microbiologists or to pathologists? An on-going dilemma
Author(s) -
Simona Venturoli,
Vittorio Sambri
Publication year - 2016
Publication title -
microbiologia medica
Language(s) - English
Resource type - Journals
eISSN - 2280-6423
pISSN - 1120-0146
DOI - 10.4081/mm.2016.5849
Subject(s) - cervical cancer , medicine , cancer , incidence (geometry) , human papilloma virus , mortality rate , gynecology , physics , optics
Among the 28 current Members of the European Union, approximately 34,000 new cases of cervical cancer occur annually, with 13,000 related deaths. In Italy, about 2900 cases of cervical cancer are diagnosed annually (crude incidence rate/100,000/year=9.4). As a direct consequence, about 1016 deaths related to cervical cancer are reported annually in Italy (crude mortality rate/100,000/year=3.3). Cervical cancer stands in the 15th rank among female cancers and is currently the 3rd most common cancer in women aged 15-44 years in Italy. [..